Peter Park‘s Park West Asset Management has recently reported its position in Eagle Pharmaceuticals Inc (NASDAQ:EGRX) through a 13G filing with the Securities and Exchange Commission. According to the filing, Park West owns 690,000 shares of Eagle Pharmaceutical and the stake, which is passive by nature, amasses 4.4% of the company’s outstanding common stock.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Park West Asset Management LLC||690,000||0||690,000||0||690,000||4.4%|
|Peter S. Park||690,000||0||690,000||0||690,000||4.4%|
Follow Peter S. Park's Park West Asset Management
Page 1 of 9 SEC Filing
EAGLE PHARMACEUTICALS, INC.
(Name of Issuer)
COMMON STOCK, $0.001 PAR VALUE PER SHARE
(Title of Class of Securities)
December 31, 2015
(Date of Event Which Requires Filing of this Statement)